Wednesday, February 5, 2025

Welcoming Victor Bornsztejn: A New Era for Culture Biosciences’ Commercial Leadership

Share

Welcoming Victor Bornsztejn as Senior Vice President of Commercial

Culture Biosciences, a leader in cloud-connected bioprocessing technologies, is excited to announce the appointment of Victor Bornsztejn as the company’s new Senior Vice President of Commercial.

In this strategic role, Victor will oversee the commercial direction of the company and lead the launch of its innovative new product, Stratyx 250.

Victor is a seasoned leader with extensive experience in the biotechnology and life sciences industries. Throughout his career, he has held numerous senior positions at leading organizations including Thermo Fisher, Sartorius, and GE Healthcare (now Cytiva). His proven track record in scaling commercial operations, driving market expansion, and overseeing the launch of cutting-edge products will be invaluable to Culture Biosciences as the company seeks to enhance its impact on the biotech industry.

CEO Chris Williams expressed enthusiasm about Victor’s new role, stating, “We are thrilled to have Victor join our team. His successful history in the commercial sector and deep knowledge of the life sciences market make him the ideal person to help us realize our vision for the future of bioprocessing.”

Victor’s appointment aligns with Culture Biosciences’ ongoing expansion of its offerings, which now include both hardware and software solutions. His contributions will be instrumental as the company continues to challenge the norms of innovation, empowering customers to accelerate scientific discovery.

About Culture Biosciences

Culture Biosciences is dedicated to innovation in upstream bioprocess development. The company’s goal is to develop new tools and services that enhance the performance, time-to-develop, and cost-efficiency of therapeutic manufacturing processes. With its proprietary, fully integrated platform that combines bioreactors, cloud-based software, and expert services, Culture Biosciences provides client companies worldwide with access to predictable and scalable bioprocess development. Founded in 2016, Culture Biosciences is based in South San Francisco, CA.

Noah Daniels
Noah Danielshttps://usatimes.io/
With a keen eye for emerging technologies and a passion for uncovering the future of innovation, Noah Daniels brings cutting-edge insights to the Innovation section. Covering everything from disruptive startups to the latest advancements in AI, renewable energy, and smart technologies, Noah translates complex concepts into engaging, accessible stories. With a background in technology and engineering, he blends technical expertise with a flair for storytelling, making his work essential reading for anyone looking to stay ahead in the rapidly evolving world of innovation. In his free time, Noah is always exploring new ideas and experimenting with the latest gadgets to understand how innovation can shape the future of our daily lives.

Read more

Local News